PHILADELPHIA — Communities in the United States that experienced the most economic distress in the wake of the Great Recession saw a significant increase in death rates from heart disease and strokes among middle-aged people, according to a new multi-institution study led by researchers at Penn Medicine. While the death rates remained nearly unchanged in counties with the least economic distress (62.6 deaths per 100,000 residents in 2010; 61.5 in 2015), areas experiencing worsening economic trends—such as high unemployment, lower median incomes and lack of affordable housing—saw a sharp increase, from 122 deaths per 100,000 residents in 2010 to 127.6 deaths in 2015.
Authors say the findings, which will be presented on Monday, Nov. 18, at the American Heart Association’s 2019 Scientific Sessions in Philadelphia, underscore how economic disparities contribute directly to health disparities.
“Our study shows that large economic trends—whether it’s a significant reduction in employment or a recession—have a real impact on communities and on the cardiovascular health of people living in those communities,” said the study’s lead author Sameed Khatana, MD, a Cardiovascular Medicine fellow at Penn Medicine. “It’s important that policymakers, physicians and even patients are aware of this increase in mortality rates. Interventions, such as policies like a health insurance expansion, may help slow this trend or even reverse it.”
After more than 50 years of steep declines, cardiovascular death rates in the United States have been nearly stagnant since 2011—with rates even rising in some groups of middle-aged adults, according to data from the Centers for Disease Control and Prevention (CDC). Although it’s known that the United States has experienced an uneven recovery following the Great Recession, it hasn’t been clear whether economic factors contribute to the varying—and, in some cases, heightened—heart disease death rates in communities nationwide.
The team, which includes researchers from Beth Israel Deaconess Medical Center and Harvard T.H. Chan School of Public Health, examined county-level cardiovascular mortality rates, spanning 2010 to 20105, for adults aged 25 to 64. They also pulled county-level values for the Distressed Communities Index, which combines seven markers of economic activity, such as income, access to housing, and educational attainment. In order to identify links between cardiovascular mortality and economic distress, the team then developed a linear regression model that included a variety of factors, such as county-level health insurance coverage, the prevalence of obesity and diabetes and density of primary care providers.
They found counties with the highest Distressed Communities Index rating at baseline also had the highest baseline cardiovascular mortality and saw largest increases in deaths from 2010 to 2015. Additionally, the counties that had worsening economic distress experienced a significantly greater increase in heart disease deaths compared to counties with the lowest ratings, independent of baseline economic distress.
“We found that it’s not a uniform increase—communities experiencing the most economic difficulties are the ones that are hardest-hit by heart disease deaths,” Khatana said.
Khatana will present the research on Monday at 11:30 am ET in Zone 3 of the Science and Technology Hall at the Pennsylvania Convention Center (1101 Arch St., Philadelphia, PA 19107).
The research was supported, in part, by a training grant from National Heart, Lung, and Blood Institute. Additional authors from Penn include Ashwin Nathan, Elias J. Dayoub and Peter W. Groeneveld.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.